You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新股配售 | 賽生藥業:逾43萬人申購,一手中籤率3%,公開認購1068.05倍,國配10倍,有綠鞋,穩價人是中金
uSMART盈立智投 03-02 12:01

uSMART盈立智投3月2日消息,賽生藥業今日公佈中籤結果,並將於今日下午進行暗盤交易。

【配售小結】

①熱情從頂點回落:相較諾輝健康-B的逾100萬人申購,賽生藥業的申購人數約43.6萬,公開認購倍數爲1,068.05倍,國配認購倍數10倍,在目前動輒幾十倍的國配數據下,國配認購算不上火爆。

②乙組比甲組熱:乙組認購倍數高達1570倍,是甲組(566倍)的近3倍。乙組繼續呈"內卷"趨勢。

③國配貨源集中:合共211名承配人,前25名承配人合共鎖定58.41%的發行股份,其中,上藥國際等11名基石合共鎖定47.53%的發行股份,禁售期6個月。也就是說,流動股份主要掌握在50%的公開散戶手中。

上市恰逢大盤調整時,賽生藥業將如何演繹?

uSMART盈立智投暗盤交易時段:3月2日16:15-18:30分

【配售簡況】

1、發售價:18.8港元,爲招股價區間(17.2-18.8港元)的上限

2、一手市值:9400港元,每手500股

3、有效申購人數:436,000名(甲組:420,697名,乙組:15,303名)

4、實際中籤人數:68,233名

5、中籤情況:一手中籤率3%,申購140手穩中1手,甲尾穩中2手,乙頭穩2爭3,頂頭槌穩中20手

6、公開認購倍數:1,068.05倍(甲組:566.01倍,乙組:1,570.09倍)

7、國配:認購倍數10倍,合共211名承配人,前25名承配人合共鎖定58.41%的發行股份

8、回撥情況:最大比例回撥,最終公開佔比50%,國配佔比50%

9、超額配股權:國際發售獲超額分配17,397,500股股份,有綠鞋

10、穩定價格操作人:中金公司

11、基石投資者:上藥國際等11名基石合共鎖定47.53%的發行股份,禁售期6個月

12、關聯客戶(2名):合共獲配768,000股發售股份,約佔發行股份的0.66%

13、uSMART盈立智投暗盤交易時段:3月2日16:15-18:30分

注:以上佔比均爲假設超額配售權未獲行使

【中籤詳情】

甲組:

一手中籤率3%

申購140手穩中1手

申購400手(甲尾)穩中2手

乙組:

申購600手(乙頭)穩2爭3

申購800手穩中3手

……

申購11599手(頂頭槌)穩中20手

以下爲中籤分配基準:

【基石投資者】

【股權集中度】

點擊可跳轉閱讀《賽生藥業發售價及配發結果公告》原文件PDF。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account